SPIMACO associate launches probe into false client documents

10/02/2019 Argaam

 

Saudi Pharmaceutical Industries and Medical Appliances Co. (SPIMACO) said in a bourse statement that a local associate has launched legal and financial investigations into forged client documents.

 

SPIMACO is likely to incur a loss of SAR 27 million for fiscal year 2017.

 

The financial impact on SPIMACO will be fully estimated for 2017 or 2018, if any, upon completion of investigations, the statement added. 

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.